Wednesday, November 17, 2021 8:18:50 AM
Fund Structure
PHILUX Global Funds and its sub-funds are organized in accordance with the following:
Legislation: Luxembourg Laws
Law of July 23, 2016 on Reserved Alternative Investment Funds (RAIF).
Law of August 23, 2016 on commercial companies.
Law of July 12, 2013 on alternative investment fund managers.
Regulation: Supervision by CSSF (Commission de Surveillance du Secteur Financier) of Luxembourg.
Segregation: Sub-funds or Compartments
Each sub-fund constitutes a separate pool of assets invested in accordance with the particular investment features applicable to such sub-fund. For the purposes of relations with creditors, each sub-fund is treated as a single entity. The assets of one sub-fund are only responsible for all debts, engagements and obligations attributable to this sub-fund. In this regard, if the Company incurs a liability, which relates to a particular sub-fund, the creditor’s recourse with respect to such liability shall be solely to the assets of the relevant sub-fund.
Duration: Unlimited or limited period of time.
Promotorship: Bank Initiator
Eligible Assets: Any kind of assets
Cash or Cash equivalents
Equity
Bonds
Derivatives
Investment funds
Private equity
Real Estate
Precious metals (gold, silver, platinum, etc.)
Arts
Other
Investments:
Direct
Through fully-owned specific purpose vehicles (Luxembourg or foreign holding companies).
Risk spreading: Risk diversification requirements (to be determined)/Look through accepted.
Form of securities: Shares:
Participating shares (owned by limited shareholders)
Management shares (owned by the General Partner)
Subscription:
Each sub-fund is reserved to a specific shareholder or a select group of shareholders (one family). New shareholder(s) are accepted according to the shareholder agreement with each sub-fund.
Subscription-based model.
In cash or in kind.
Subscription fees possible.
Depository: Hauck & Aufhauser Luxembourg
Administration: Luxembourg Central administration.
AIFMD Management: Delegation to AIF ManCo.
Investment Management:
The General Partners conduct the investment management with a regulated investment manager, which follows guidelines and rules fixed by each sub-fund committee.
Risk Management: Delegation to AIF ManCo.
Audit: External independent Luxembourg CSSF-regulated auditor required.
Financial reporting:
Audited annual report
LuxGAAP/IFRS
Wealth tax: Exempt.
http://www.philux.eu/fund-structure/
Recent PHIL News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 03/11/2024 10:05:47 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/21/2024 12:34:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/26/2023 03:00:09 PM
- US Airforce Contract Awarded to Epazz, Inc. (OTC Pink: EPAZ) • InvestorsHub NewsWire • 12/14/2023 11:48:21 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/13/2023 08:40:50 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:15:52 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/13/2023 09:33:15 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/13/2023 08:10:38 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 09/28/2023 08:30:15 PM
- Airbus, PHI Group Sign Deal for 28 Helicopters • Dow Jones News • 09/12/2023 01:58:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/03/2023 12:00:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/29/2023 03:30:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/28/2023 09:00:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/28/2023 08:45:44 PM
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM